ReviewArchives of microbiology2026
Quorum sensing in bacteria: insights into communication and inhibition strategies-a review.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Quorum-quenching enzymes as next-generation antibiofilm therapeutics: mechanisms, applications, and future perspectives.World journal of microbiology & biotechnology · 2026Review
- Quorum sensing rewires membrane vesicle protein cargo to promote antibiotic persistence inJournal of bacteriology · 2026Article
- Suppression of Quorum Sensing and Virulence Factors by Meloxicam and Celecoxib in Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2026Article
- Microbial quorum sensing signals, symbiosis, secrets and sabotage.Microbiology (Reading, England) · 2026Review
- Advancements in Technologies Targeting Horizontal Gene TransferRoutes to Control Drug Resistance Evolution.ACS bio & med chem Au · 2026Review
- Quorum Sensing and Quorum Quenching in Periodontal Disease: Mechanisms and Therapeutic Potential.Current issues in molecular biology · 2026Review
- Quorum Sensing and Quorum Quenching in Pseudomonas aeruginosa and Staphylococcus aureus Infections: Therapeutic Potential, Limitations and Clinical Challenges.Antibiotics (Basel, Switzerland) · 2026Review
- Trojan Horses: Conjugating Siderophores and Antibiotics-A New Approach to TreatingMicroorganisms · 2026Review
- Mixed-species biofilms in food systems: from community assembly to ecology-informed management.Frontiers in microbiology · 2026Review
- A green approach for synthesizing zinc oxide nanoparticles utilizing aqueous extract of lemon peel: antibacterial evaluation and in silico analysis.Frontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quorum sensing (QS) is a fundamental bacterial communication mechanism that promotes population-dependent behaviors including biofilm formation, virulence, and sporulation via signaling molecules called autoinducers. This review provides a comprehensive overview of QS and quorum sensing-mediated cross-talk in Gram-negative bacteria using N-acyl-homoserine lactones (AHLs), Gram-positive bacteria employing oligopeptides, and the universal autoinducer-2 (AI-2) system. Advances in synthetic biology and engineered QS circuits have improved understanding and control of microbial communication. The review highlights quorum quenching (QQ) and diverse classes of quorum sensing inhibitors (QSIs)-natural, synthetic, antibody-based, enzymatic, CRISPR-mediated, and those currently in clinical trials-focusing on their potential to interfere with signaling pathways and attenuate virulence. The interplay between QS, antimicrobial resistance (AMR), and QSIs is examined, emphasizing their capability to suppress pathogenicity without inducing resistance. Recent emerging approaches for QS regulation have also been mentioned. The applications of QS-targeted strategies in healthcare, agriculture, aquaculture, food industry, and medical device biofilm management are discussed, underscoring the translational promise of QSIs as sustainable, resistance-free tools for effective antimicrobial control.
Indexed as
Identifiers
41627464What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.